Navidea Biopharmaceuticals Announces Issuance of New U.S. Patent Covering Formulation for Neuroimaging Agent, NAV5001 Nov 14, 2013
Navidea to Collaborate with University of California–San Francisco on Clinical Study Evaluating Manocept™ Platform Imaging Agent in Kaposi Sarcoma (KS) Patients Nov 13, 2013
Navidea Biopharmaceuticals Schedules Third Quarter 2013 Financial Results Conference Call Oct 30, 2013
Navidea Biopharmaceuticals Manocept™ Platform Featured in Nature Outlook: Medical Imaging Oct 24, 2013
SAVE THE DATE: Navidea Biopharmaceuticals to Host Analyst Science Day December 5, 2013 in New York City Oct 16, 2013
Navidea Biopharmaceuticals Announces Additional Results from Lymphoseek® Phase 3 Clinical Trial in Head and Neck Cancer at American College of Surgeons 2013 Annual Clinical Congress Oct 7, 2013
Navidea Biopharmaceuticals to Present at BioCentury’s NewsMakers in the Biotech Industry Conference Sep 24, 2013
Navidea Biopharmaceuticals Completes $30 Million Registered Direct Offering of Common Stock Sep 24, 2013
